Public trial registry of the CCC-Munich

Trial DESTINY-Gastric03

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
DESTINY-Gastric03
World
Full title
:

A Phase 1b/2 Multicenter, Open-label, Dose-escalation and Dose-expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of Trastuzumab Deruxtecan (T-DXd) Monotherapy and Combinations in Adult Participants with HER2-Overexpressing Gastric Cancer

World
Responsible organization
:
3. Med 3. Med Ismaninger Str. 22 81675 München Germany
Indications
Classification Code Description
- Stomach carcinoma
Trial design
World
Phase
:
I/II
Status
World
Status
:
Recruitment finished
Votes
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Therapy
World
Therapy
:

Chemo,Zielgerichtet

Participants
Function Prename Surname Organization
World Responsible contact Sylvie Lorenzen 3. Med 3. Med Ismaninger Str. 22 81675 München Germany Magnifier